Hedge Fund - Tang Capital Management
La Jolla Pharmaceutical Co (LJPC)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2022 - Q3 (2022-09-30) | $0 | 0% | 0 | $5.78 |
| 2 | 2022 - Q2 (2022-06-30) | $30,649,000 | 4.65% | 9,607,934 | $3.90 |
| 3 | 2022 - Q1 (2022-03-31) | $41,026,000 | 8.2% | 9,607,934 | $4.36 |
| 4 | 2021 - Q4 (2021-12-31) | $44,677,000 | 8.98% | 9,607,934 | $4.17 |
| 5 | 2021 - Q3 (2021-09-30) | $40,096,000 | 8.32% | 10,049,224 | $3.97 |
| 6 | 2021 - Q2 (2021-06-30) | $43,011,000 | 8.56% | 10,049,224 | $4.28 |
| 7 | 2021 - Q1 (2021-03-31) | $39,879,000 | 11.21% | 9,405,490 | $5.51 |
| 8 | 2020 - Q4 (2020-12-31) | $36,493,000 | 5.57% | 9,405,490 | $4.27 |
| 9 | 2020 - Q3 (2020-09-30) | $37,904,000 | 6.85% | 9,405,490 | $4.14 |
| 10 | 2020 - Q2 (2020-06-30) | $37,043,000 | 3.6% | 8,695,474 | $6.09 |
| 11 | 2020 - Q1 (2020-03-31) | $33,937,000 | 4.76% | 8,080,345 | $6.32 |
| 12 | 2019 - Q4 (2019-12-31) | $19,410,000 | 2.31% | 4,938,893 | $5.91 |
| 13 | 2019 - Q3 (2019-09-30) | $43,462,000 | 7.43% | 4,938,893 | $9.45 |
| 14 | 2019 - Q2 (2019-06-30) | $45,685,000 | 6.17% | 4,938,893 | $7.54 |
| 15 | 2019 - Q1 (2019-03-31) | $31,757,000 | 5.85% | 4,938,893 | $6.51 |
| 16 | 2018 - Q4 (2018-12-31) | $36,578,000 | 8.39% | 3,878,893 | $15.05 |
| 17 | 2018 - Q3 (2018-09-30) | $83,316,000 | 13.6% | 4,138,893 | $26.14 |
| 18 | 2018 - Q2 (2018-06-30) | $120,732,000 | 15.3% | 4,138,893 | $30.87 |
| 19 | 2018 - Q1 (2018-03-31) | $123,256,000 | 18.11% | 4,138,893 | $32.24 |
| 20 | 2017 - Q4 (2017-12-31) | $110,713,000 | 17.54% | 3,440,419 | $32.68 |
| 21 | 2017 - Q3 (2017-09-30) | $119,658,000 | 36.53% | 3,440,419 | $32.16 |
| 22 | 2017 - Q2 (2017-06-30) | $102,421,000 | 36.35% | 3,440,419 | $28.66 |
| 23 | 2017 - Q1 (2017-03-31) | $102,697,000 | 37.11% | 3,440,419 | $25.53 |
| 24 | 2016 - Q4 (2016-12-31) | $55,941,000 | 29.83% | 3,191,165 | $19.17 |
| 25 | 2016 - Q3 (2016-09-30) | $75,918,000 | 31.48% | 3,191,165 | $18.84 |
| 26 | 2016 - Q2 (2016-06-30) | $48,834,000 | 21.75% | 3,052,130 | $17.94 |
| 27 | 2016 - Q1 (2016-03-31) | $63,820,000 | 29.06% | 3,052,130 | $17.84 |
| 28 | 2015 - Q4 (2015-12-31) | $77,548,000 | 30.77% | 2,872,130 | $27.27 |
| 29 | 2015 - Q3 (2015-09-30) | $81,007,000 | 29.87% | 2,914,970 | $31.51 |
| 30 | 2015 - Q2 (2015-06-30) | $65,318,000 | 19.81% | 2,664,970 | $20.61 |
| 31 | 2015 - Q1 (2015-03-31) | $39,242,000 | 20.87% | 2,144,387 | $20.27 |
| 32 | 2014 - Q4 (2014-12-31) | $39,564,000 | 21.69% | 2,144,387 | $11.87 |
| 33 | 2014 - Q3 (2014-09-30) | $18,369,000 | 9.51% | 1,911,462 | $9.95 |
| 34 | 2014 - Q2 (2014-06-30) | $8,096,000 | 3.74% | 881,907 | $9.13 |
| 35 | 2014 - Q1 (2014-03-31) | $121,000 | 0.05% | 11,219 | $9.81 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:50.0000 on 2014-01-14